Answers are grounded in this paper and cite their sources.
Double-blind trial demonstrates L-glutamine and hydroxyurea reduce complications in sickle cell anemia, suggesting improved treatment options.
Adding L-glutamine to HU significantly reduced VOCs, ACS, and hospitalizations, while improving hemoglobin and hemolysis markers, without added toxicity. The combination's efficacy likely reflects synergistic effects on oxidative stress and sickle cell pathophysiology. This well-tolerated combination may improve SCA control, but larger confirmatory trials are needed.
No takes yet. Share an insight, caveat, or question.
Shakibazad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: